
Bupain 400mg/325mg/250mg Tablet MR
Marketer
Jarson Pharmaceuticals
Salt Composition
Ibuprofen (400mg) + Paracetamol (325mg) + Chlorzoxazone (250mg)
Overview Bupain 400mg/325mg/250mg Tablet MR
Combiflex, a 400mg/325mg/250mg modified-release tablet, treats muscle spasm pain. It eases muscle movement and alleviates associated discomfort. Combiflex may be administered independently or alongside other medications, and should always be taken with food to minimize stomach upset. Follow your physician's instructions precisely; avoid exceeding the prescribed dosage or duration. Common side effects include nausea, dyspepsia, abdominal pain, fatigue, vertigo, and somnolence. Report any persistent or worsening side effects to your doctor, who can advise on management strategies. This medication isn't universally suitable; inform your doctor of any pre-existing conditions or medications before commencing treatment. Pregnant or lactating individuals require prior medical consultation before use.
Uses of Bupain 400mg/325mg/250mg Tablet MR
Managing musculoskeletal pain stemming from muscle contractions
Major Benefits of Bupain 400mg/325mg/250mg Tablet MR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Bupain 400mg/325mg/250mg Modified-Release tablet should be taken with a meal.
Common Side effects of Bupain 400mg/325mg/250mg Tablet MR:
- Nausea
- Indigestion
- Stomach pain
- Weakness
- Dizziness
- Sleepiness
- Heartburn
How to use Bupain 400mg/325mg/250mg Tablet MR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing. Consume the Bupain 400mg/325mg/250mg Modified-Release tablet with a meal.
How Bupain 400mg/325mg/250mg Tablet MR works:
Each Bupain MR tablet (400mg ibuprofen, 325mg paracetamol, 250mg chlorzoxazone) combines analgesic and muscle relaxant actions. Ibuprofen and paracetamol suppress pain and inflammation by inhibiting the production of pain-signaling chemicals. Chlorzoxazone's effect on the central nervous system reduces muscle tension and spasms, promoting improved mobility.
SAFETY ADVICE
AlcoholUNSAFE
Combining Bupain 400mg/325mg/250mg MR tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Bupain 400mg/325mg/250mg MR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Bupain 400mg/325mg/250mg MR tablets with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Extended-release Bupain tablets (400mg/325mg/250mg) can induce adverse reactions that might impair driving ability.
KidneyCAUTION
Patients with kidney impairment should use Bupain 400mg/325mg/250mg MR tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Bupain 400mg/325mg/250mg MR tablets are contraindicated in patients with severe renal disease. Prolonged Bupain 400mg/325mg/250mg MR tablet use may compromise kidney function.
LiverCAUTION
Patients with liver impairment should use Bupain 400mg/325mg/250mg MR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Bupain 400mg/325mg/250mg MR tablets are contraindicated in individuals with severe or active liver disease.
What if you forget to take Bupain 400mg/325mg/250mg Tablet MR :
For a missed Bupain 400mg/325mg/250mg MR Tablet, take it promptly if remembered. Near the time for your next dose, however, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Bupain 400mg/325mg/250mg Tablet MR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Pain Relievers |
